Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 1,382 | 187 | 151 | 68 | 26 |
| Gross Profit | 1,382 | 187 | 151 | 68 | 26 |
| Operating Expenses | 14,899 | 13,567 | 15,017 | 11,099 | 13,116 |
| Operating Income | -13,517 | -13,380 | -14,866 | -11,031 | -13,090 |
| Interest Expense | 232 | 370 | 358 | 124 | 206 |
| Other Income | 564 | 641 | 632 | 200 | 88 |
| Pre-tax Income | -13,185 | -13,109 | -14,592 | -10,955 | -13,208 |
| Net Income Continuous | -13,185 | -13,109 | -14,592 | -10,955 | -13,208 |
| Net Income | $-13,185 | $-13,109 | $-14,592 | $-10,955 | $-13,208 |
| EPS Basic Total Ops | -0.29 | -0.29 | -0.37 | -0.31 | -0.37 |
| EPS Basic Continuous Ops | -0.29 | -0.29 | -0.37 | -0.31 | -0.37 |
| EPS Diluted Total Ops | -0.29 | -0.29 | -0.37 | -0.31 | -0.37 |
| EPS Diluted Continuous Ops | -0.29 | -0.29 | -0.37 | -0.31 | -0.37 |
| EBITDA(a) | $-13,445 | $-13,343 | $-14,873 | $-10,922 | $-12,866 |